Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001392380-23-000099
Filing Date
2023-11-14
Accepted
2023-11-14 09:05:42
Documents
101
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gevo-20230930x10q.htm   iXBRL 10-Q 2340266
2 EX-31.1 gevo-20230930xex31d1.htm EX-31.1 11465
3 EX-31.2 gevo-20230930xex31d2.htm EX-31.2 11067
4 EX-32.1 gevo-20230930xex32d1.htm EX-32.1 7996
  Complete submission text file 0001392380-23-000099.txt   10651667

Data Files

Seq Description Document Type Size
5 EX-101.SCH gevo-20230930.xsd EX-101.SCH 69162
6 EX-101.CAL gevo-20230930_cal.xml EX-101.CAL 85125
7 EX-101.DEF gevo-20230930_def.xml EX-101.DEF 230663
8 EX-101.LAB gevo-20230930_lab.xml EX-101.LAB 611092
9 EX-101.PRE gevo-20230930_pre.xml EX-101.PRE 450444
95 EXTRACTED XBRL INSTANCE DOCUMENT gevo-20230930x10q_htm.xml XML 2220425
Mailing Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112
Business Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112 303-858-8358
Gevo, Inc. (Filer) CIK: 0001392380 (see all company filings)

EIN.: 870747704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35073 | Film No.: 231401943
SIC: 2860 Industrial Organic Chemicals